Contact Us   |   Sign In   |   Register
139th KPhA Annual Meeting and Convention
Tell a Friend About This EventTell a Friend
 

6/22/2017 to 6/25/2017
Where: Griffin Gate Marriott Resort & Spa
1800 Newtown Pike
Lexington, Kentucky  40511
United States
Contact: Scott Sisco
502-227-2303


Online registration is closed.
« Go to Upcoming Event List  

139th KPhA Annual Meeting and Convention

  

As a reminder, the Ray Wirth Banquet is an additional charge ($25 for registrants, $50 for guests, $5 for students). All other meals are included in your registration. OUR KPhA implemented this to better plan for the banquet to avoid extra costs. 

If you plan to attend the banquet, but did not order your ticket, you can do so by:

1.       Clicking on the register link on the Annual Meeting calendar item on the KPhA website and adding this to your registration.

2.       Calling the KPhA office at 502-227-2303.

We will sell tickets at the registration desk on site, but early registration allows us to better plan for the event.

Also, if you did not check which meals you will attend, please let Scott Sisco know at ssisco@kphanet.org or call 502-227-2303.

   

HOST HOTEL INFORMATION

Griffin Gate Marriott Resort and Spa is the host hotel for the 139th KPhA Annual Meeting & Convention. Book your room now at a reduced rate of $139/night for single and double occupancy. Overnight accommodations can be made by clicking here, or by calling 1-800-266-9432 before JUNE 9, 2017 to receive the group rate. The group name is Ky Pharmacist Association Annual Meeting 2017.

 

Thursday, June 22, 2017

KPERF Golf Scramble

11:30 am                              Registration                                        Noon          Shotgun start                                                              

 

Friday, June 23, 2017

7 am                                      Registration Opens

7:30 am               Opening Breakfast/KPhA Annual Membership Meeting and Opening House of Delegates

9:00 am – 10:00 am        

An Ounce of Prevention: An Opioid Misuse Reduction Strategy    0143-0000-17-032-L04-P&T

Douglas Oyler, PharmD, Clinical Pharmacist, Trauma & Emergency General Surgery, UK HealthCare

Learning Objectives – At the completion of this program, the participant will be able to:

1.Describe major factors that led to the current opioid crisis, specifically the role of medical
prescribing;

2.Apply successes from a trauma pilot program to other key patient populations;

3.List key interventions described in guidelines to reduce inappropriate prescribing; and,

4.List interventions for an opioid stewardship team.

 

10:10 – 11:10 am             

A Culture of Patient Safety                                                                   0143-0000-17-033-L05 P&T

Don R. McGuire, Jr., RPh, JD, General Counsel, Sr.VP Risk Management & Compliance,
Pharmacists Mutual

Learning Objectives – At the completion of this program, the participant will be able to:

1.List two major groups of factors that contribute to prescription errors and near-misses;

2.State the relationship of discovered to undiscovered errors derived from research;

3.List two techniques or best practices that reduce the number of prescription errors; and,

4.Identify where more errors and near-misses occur during the dispensing process.

 

11:25-12:45 pm                 KPhA Awards Luncheon

1:00 – 2:00                          

Expanding the Role of Pharmacists = Expanding Patient Access to Care           0143-0000-17-34-L04-P&T

Thomas Menighan, BSPharm, MBA, ScD, FAPhA, EVP/CEO, APhA

Learning Objectives – At the completion of this program, the participant will be able to:

1.Outline the details of federal provider status legislation and recent activity;

2.Explain state-level opportunities that may increase patient access to pharmacists’ services;

3.Describe how success at the federal and state level can impact pharmacists and their practice; and,

4.Discuss ways to advocate and get involved.

 

2:10 -3:40                            

Senate Bill 101: Impact on Pharmacy Practice                                   0143-0000-17-035-L03-P&T

Clark Kebodeaux, PharmD, BCACP, Clinical Assistant Professor, UKCOP

Learning Objectives – At the completion of this program, the participant will be able to:

1.—Define the contents of Senate Bill 101 and the potential impact for pharmacy practice in
Kentucky (P&T);

2.Describe the Advisory Committee on Immunization Practices (ACIP) updates and
recommendations for vaccination (P&T); and,

3.Discuss a patient’s immunization and medical history to provide appropriate recommendations (P) Discuss a patient’s immunization and medical history (T).

 

3:50-5:20 pm                     

2017 NASPA/NMA Student Pharmacist Self Care Championship    0143-0000-17-036-L04-P&T

Host: Jody Jaggers, KPhA Director of Pharmacy Emergency Preparedness

Learning Objectives – At the completion of this program, the participant will be able to:

1.Identify and explain aspects of the effective and safe practice of pharmacy self-care treatments;

2.Describe at least two over the counter and prescription medication interactions of which
pharmacists and pharmacy technicians should be aware;

3.List three OTC medications and their use. Pharmacists should identify counseling points for each of three OTC medications.

 

5:30 pm-7:30 pm              Opening of Hall of Exhibits

 

Saturday, June 24, 2017

7:00 am                                Registration/Continental Breakfast

7:00 am                                Reference Committee

8-9:30 am                           Kentucky Legislative and Law Update 2017                                         0143-0000-17-037-L03-P&T
Ralph E. Bouvette, BS Pharm, PhD, JD, Executive Vice President, APSC
Learning Objectives – At the completion of this program, the participant will be able to:
Identify current policy issues at the state level related to pharmacy and pharmacy practice;
Identify recent changes to state law that impact the practice of pharmacy;
Implement changes in his or her professional practice to comply with recent changes in state law impacting the practice of pharmacy.


9:30 am to 11 am              Hall of Exhibits Open

11 am to noon                  

Preceptor Development: Let’s all Speak the Same Language – Pharmacist Patient Care
Process                                                                                                          0143-0000-17-038-L04-P

Anne Policastri, Pharm.D., MBA, FKSHP, FASHP, Director of Experiential Education, University of Kentucky College of Pharmacy; Misty M. Stutz, PharmD, Assistant Dean and Chair, Clinical and
Administrative Sciences, Sullivan University College of Pharmacy

Learning Objectives – At the completion of this program, the participant will be able to:

1.Review the background involved in creation of the Pharmacists’ Patient Care Process;

2.Define each component of the Pharmacists’ Patient Care Process and describe how it is used; and,

3.Discuss preceptor assessment of the student using the components of the Pharmacists’
Patient Care Process.

 

11 am to noon                  

Exploring the New Terrain of New & Emerging Diabetes Medications
                                                                                                                   0143-0000-17-039-L01-P&T

Lourdes Cross, PharmD, BCACP, CDE, Assistant Professor, Clinical and Administrative Sciences, Sullivan University College of Pharmacy

Learning Objectives – At the completion of this program, the participant will be able to:

1.Summarize updated guideline recommendations for the treatment and management of diabetes (P&T);

2.Describe characteristics of new and emerging antihyperglycemic agents, including mechanism of action, dosage and administration, and adverse effects (P&T); and,

3.Select among antihyperglycemic medications taking into consideration individual patient contexts (P).

 

Noon                                     College Update and Preceptor Recognition Luncheon

Noon                                     Technician Lunch/Academy meeting

1:00-2:30 pm                     

2017 New Drugs: How Do They Stack Up?                                           0143-0000-17-040-L04-P&T

Trish Rippetoe Freeman, RPh, PhD, Associate Professor and Director, Center for the Advancement of Pharmacy Practice, UKCOP

Learning Objectives – At the completion of this program, the participant will be able to:

1.Identify select new molecular and biological entities, with the exception of diagnostic compounds, that entered the US market in 15-16.

2.Describe each agent’s clinical use, mechanism of action, dosage, adverse reactions, contraindications, and drug interaction profile.

3.Compare new medicines with other agents used for the same indications.

 

2:40: 3:40 pm                    

Shaping the Workforce of Tomorrow: Preparing Technicians for Advanced Roles

                                                                                                                    0143-0000-17-041-L04-P&T

Ashlee Mattingly, PharmD, BCPS,  PharmTechX Coordinator, University of Maryland School of
Pharmacy & Sarah Lawrence, PharmD, MA, BCGP,  Director, Pharmacy Technician Program Assistant Professor,  Sullivan University College of Pharmacy

Learning Objectives – At the completion of this program, the participant will be able to:

1.Review the position statements of APhA and ASHP regarding the advancement of pharmacy technicians;

2.Describe existing advanced roles for pharmacy technicians in different practice settings;

3.Discuss the challenges and opportunities associated with preparing pharmacy technicians for advanced roles in pharmacy practice; and,

4.Illustrate the ways that advanced pharmacy technicians can benefit the practice of pharmacy and promote the health and well-being of patients.

 

2:40: 3:40 pm                    

The Expanding Role of Pharmacists In Opioid Addiction Treatment: Long-Acting Injectables

                                                                                                                    0143-0000-17-042-L01-P&T

Emily Blaiklock, PharmD, PGY-1, Sullivan University College of Pharmacy/St. Matthews Community Pharmacy

Learning Objectives – At the completion of this program, the participant will be able to:

1.Recognize the need for alternative methods of opioid addiction treatment;

2.Identify the strengths and weaknesses of the current agents on the market used in opioid
addiction treatment;

3.Explain the administration technique for the long-acting injectable used in opioid addiction
treatment; and,

4.Discuss the benefits associated with pharmacists taking a leadership role in the long-acting
injectables used in the treatment of opioid addiction.

 

3:45 pm-5:30 pm              House of Delegates Closing Session

6 pm                                      President’s Reception

7 pm                                      Ray Wirth Banquet (stick around after for networking with colleagues)

 

Sunday, June 25, 2017

8:30 am                                Breakfast/Non-CE Learning Presentation (Novo Nordisk)

9:30 am                                KPhA Board of Directors New Member Orientation

9:45 am-11:45 am           

Protocol-authorized Smoking Cessation: What's a Pharmacist to do? 
                                                                                                                 0143-0000-17-043-L04-P&T

Melody Ryan, PharmD, MPH, Professor, University of Kentucky College of Pharmacy

Learning Objectives – At the completion of this program, the participant will be able to:

1.Plan for pharmacist implementation of Senate Bill 89;

2.Apply the transtheoretical model of change to smoking cessation; and,

3.Implement nicotine replacement therapy to assist patients with smoking cessation.

 

RELATED PRODUCTS
EVENT PHOTOS
Membership Software Powered by YourMembership  ::  Legal